Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
2(14%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
4
29%
Ph phase_4
1
7%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(7)
Terminated(2)
Other(3)

Detailed Status

Completed7
unknown3
Withdrawn1
Active, not recruiting1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (20.0%)
N/A4 (80.0%)

Trials by Status

unknown321%
withdrawn17%
active_not_recruiting17%
completed750%
recruiting17%
terminated17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
PROCEDURE
Total Trials
14